A detailed history of Financial Advisory Group transactions in Abbott Laboratories stock. As of the latest transaction made, Financial Advisory Group holds 3,550 shares of ABT stock, worth $405,516. This represents 0.07% of its overall portfolio holdings.

Number of Shares
3,550
Previous 3,550 -0.0%
Holding current value
$405,516
Previous $390,000 3.33%
% of portfolio
0.07%
Previous 0.08%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$90.19 - $110.4 $22,547 - $27,600
250 Added 7.58%
3,550 $390,000
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $48,573 - $56,239
-502 Reduced 13.2%
3,300 $319,000
Q2 2022

Aug 10, 2022

BUY
$102.07 - $123.37 $204 - $246
2 Added 0.05%
3,802 $413,000
Q1 2022

May 12, 2022

BUY
$114.02 - $139.04 $342 - $417
3 Added 0.08%
3,800 $450,000
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $115 - $141
1 Added 0.03%
3,797 $534,000
Q3 2021

Nov 09, 2021

BUY
$116.66 - $129.06 $233 - $258
2 Added 0.05%
3,796 $448,000
Q2 2021

Aug 10, 2021

BUY
$105.79 - $124.53 $52,260 - $61,517
494 Added 14.97%
3,794 $440,000
Q1 2021

May 14, 2021

SELL
$108.84 - $128.23 $53,440 - $62,960
-491 Reduced 12.95%
3,300 $395,000
Q4 2020

Feb 12, 2021

BUY
$105.0 - $114.42 $51,555 - $56,180
491 Added 14.88%
3,791 $415,000
Q3 2020

Nov 12, 2020

SELL
$91.64 - $111.29 $3,665 - $4,451
-40 Reduced 1.2%
3,300 $359,000
Q2 2020

Aug 13, 2020

BUY
$76.57 - $98.0 $3,062 - $3,920
40 Added 1.21%
3,340 $305,000
Q3 2019

Nov 12, 2019

SELL
$81.84 - $88.74 $49,104 - $53,244
-600 Reduced 15.38%
3,300 $276,000
Q2 2019

Aug 12, 2019

BUY
$72.88 - $85.0 $43,728 - $51,000
600 Added 18.18%
3,900 $334,000
Q2 2018

Aug 08, 2018

SELL
$57.57 - $63.54 $11,514 - $12,708
-200 Reduced 5.71%
3,300 $201,000
Q1 2018

May 14, 2018

BUY
$56.27 - $63.62 $196,945 - $222,670
3,500 New
3,500 $210,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Financial Advisory Group Portfolio

Follow Financial Advisory Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Financial Advisory Group with notifications on news.